Seed Round

A new $50M fund unites venture capital with Canada's top cancer charities, aiming to fast-track lab discoveries into life-saving patient treatments.

Enabled Talent launches a fellowship with a radical promise: it won't end until participants secure a job, bridging the gap from readiness to results.

UTime's latest capital raise is a fraction of its needs. We dive into the firm's mounting losses, stock dilution, and what this means for its future.

With new FDA clearance, Zeta Surgical's portable AI navigation system could bring millimeter-precision brain surgery to any hospital, not just elite centers.

AI-native firm Norm Law adds veteran tax and fund formation counsel, deepening its tech-driven challenge to the traditional legal services model for investors.

A new AI platform promises to fix billions in revenue loss from complex cardiac coding, but will it empower or replace human experts in the process?

A new partnership between a sports tech startup and an NFL star's foundation reveals how AI is set to revolutionize training for everyday athletes.

A new five-year partnership seeks to bridge the gap between clinical insight and investment, speeding up patient access to new medical technologies.

A $10T wave of business sales is coming. A new partnership aims to de-risk these deals for everyday entrepreneurs with insurance once reserved for Wall Street.

With a €1.4M EU grant, a Lithuanian startup launches AI tools to combat failed payments and empower fintech innovation across Europe.

AI Council 2026 reveals the industry's next chapter: European founders are flocking to SF, engineering is being reinvented, and video is set to break everything.

A Silicon Valley firm's new patent could end reactive cybersecurity by translating raw data into meaningful, predictive intelligence for AI systems.

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

A medtech startup received a major NIH award to develop a wearable AI that predicts SUDEP, a deadly complication of epilepsy, offering new hope for patients.

After a $700M exit with Peakon and leading a space-tech venture, serial entrepreneur Phil Chambers brings deep operational expertise to Balderton.

For the 5th straight year, WA's life sciences outpace job growth. See how AI leadership and strategic investment fuel its $43.4B economic impact.

HCL Group and the WEF's UpLink are seeking innovators to solve the global water crisis with a new challenge aimed at transforming our future water systems.

With a seasoned dealmaker at the helm, Elkedonia is advancing a first-in-class, non-hallucinogenic drug for depression targeting a novel protein.

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.